Incyte Historical Income Statement

INCY Stock

USD 52.72 0.50 0.94%

Historical analysis of Incyte income statement accounts such as Total Revenue of 3.9 B or Gross Profit of 3.6 B can show how well Incyte performed in making a profits. Evaluating Incyte income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Incyte's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Incyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Incyte is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

About Incyte Income Statement Analysis

Incyte Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Incyte shareholders. The income statement also shows Incyte investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Incyte Income Statement Chart

Incyte Income Statement is one of the three primary financial statements used for reporting Incyte's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Incyte revenue and expense. Incyte Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, Incyte's Total Other Income Expense Net is fairly stable compared to the past year. Net Income is likely to rise to about 627.5 M in 2024, whereas Interest Expense is likely to drop slightly above 2.4 M in 2024.

Total Revenue Other Operating Expenses Cost Of Revenue Total Operating Expenses

Total Revenue

Total revenue comprises all receipts Incyte generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Incyte. It is also known as Incyte overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Incyte income statement and represents the costs associated with goods and services Incyte provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Incyte's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Incyte current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.At this time, Incyte's Total Other Income Expense Net is fairly stable compared to the past year. Net Income is likely to rise to about 627.5 M in 2024, whereas Interest Expense is likely to drop slightly above 2.4 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.2B	2.6B	2.8B	2.9B
Cost Of Revenue	151.0M	207.0M	255M	267.8M

Total Operating Expenses Cost Of Revenue

Incyte income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling General Administrative	Extraordinary Items	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Depreciation And Amortization		-0.23	0.63	0.63	0.58	0.6	0.64	0.68	0.52	0.57	0.65	0.3	0.46	0.59	0.47	0.69	0.53	0.43	0.48	0.56	0.7	0.73	0.62	-0.27
Interest Expense	-0.23		-0.71	-0.71	-0.72	-0.45	-0.48	-0.48	-0.47	-0.72	-0.49	-0.24	-0.45	-0.16	-0.73	-0.63	0.18	-0.39	-0.4	-0.14	-0.29	-0.57	-0.46	0.58
Total Revenue	0.63	-0.71		1.0	0.98	0.75	0.78	0.79	0.75	0.98	0.78	0.26	0.69	0.35	0.92	0.97	0.36	0.66	0.62	0.31	0.52	0.81	0.77	-0.87
Gross Profit	0.63	-0.71	1.0		0.98	0.75	0.78	0.79	0.75	0.98	0.78	0.26	0.68	0.34	0.92	0.97	0.37	0.66	0.62	0.31	0.51	0.8	0.77	-0.87
Other Operating Expenses	0.58	-0.72	0.98	0.98		0.61	0.66	0.67	0.73	1.0	0.66	0.2	0.55	0.36	0.97	0.93	0.38	0.53	0.54	0.32	0.44	0.78	0.7	-0.87
Operating Income	0.6	-0.45	0.75	0.75	0.61		0.99	0.98	0.59	0.6	0.98	0.39	0.95	0.22	0.43	0.82	0.2	0.91	0.71	0.18	0.61	0.64	0.79	-0.63
Ebit	0.64	-0.48	0.78	0.78	0.66	0.99		1.0	0.66	0.64	1.0	0.4	0.93	0.31	0.47	0.86	0.2	0.87	0.73	0.27	0.72	0.75	0.85	-0.67
Ebitda	0.68	-0.48	0.79	0.79	0.67	0.98	1.0		0.66	0.65	1.0	0.4	0.92	0.33	0.48	0.87	0.23	0.86	0.73	0.29	0.73	0.76	0.85	-0.66
Cost Of Revenue	0.52	-0.47	0.75	0.75	0.73	0.59	0.66	0.66		0.72	0.64	0.13	0.51	0.38	0.63	0.79	0.33	0.47	0.54	0.38	0.58	0.73	0.72	-0.71
Total Operating Expenses	0.57	-0.72	0.98	0.98	1.0	0.6	0.64	0.65	0.72		0.64	0.2	0.54	0.35	0.98	0.92	0.38	0.52	0.53	0.31	0.43	0.77	0.68	-0.86
Income Before Tax	0.65	-0.49	0.78	0.78	0.66	0.98	1.0	1.0	0.64	0.64		0.47	0.93	0.31	0.48	0.85	0.19	0.87	0.75	0.27	0.73	0.75	0.83	-0.65
Total Other Income Expense Net	0.3	-0.24	0.26	0.26	0.2	0.39	0.4	0.4	0.13	0.2	0.47		0.43	0.17	0.17	0.21	-0.05	0.38	0.67	0.15	0.46	0.27	0.17	-0.16
Net Income	0.46	-0.45	0.69	0.68	0.55	0.95	0.93	0.92	0.51	0.54	0.93	0.43		-0.07	0.4	0.72	0.16	0.98	0.62	-0.1	0.5	0.56	0.65	-0.59
Income Tax Expense	0.59	-0.16	0.35	0.34	0.36	0.22	0.31	0.33	0.38	0.35	0.31	0.17	-0.07		0.27	0.45	0.11	-0.17	0.43	1.0	0.66	0.56	0.55	-0.23
Research Development	0.47	-0.73	0.92	0.92	0.97	0.43	0.47	0.48	0.63	0.98	0.48	0.17	0.4	0.27		0.81	0.37	0.39	0.44	0.24	0.28	0.67	0.53	-0.8
Selling General Administrative	0.69	-0.63	0.97	0.97	0.93	0.82	0.86	0.87	0.79	0.92	0.85	0.21	0.72	0.45	0.81		0.35	0.67	0.62	0.41	0.64	0.87	0.87	-0.86
Extraordinary Items	0.53	0.18	0.36	0.37	0.38	0.2	0.2	0.23	0.33	0.38	0.19	-0.05	0.16	0.11	0.37	0.35		0.25	0.15	0.11	0.16	0.27	0.38	-0.23
Net Income From Continuing Ops	0.43	-0.39	0.66	0.66	0.53	0.91	0.87	0.86	0.47	0.52	0.87	0.38	0.98	-0.17	0.39	0.67	0.25		0.59	-0.21	0.37	0.45	0.57	-0.55
Non Operating Income Net Other	0.48	-0.4	0.62	0.62	0.54	0.71	0.73	0.73	0.54	0.53	0.75	0.67	0.62	0.43	0.44	0.62	0.15	0.59		0.41	0.59	0.49	0.59	-0.53
Tax Provision	0.56	-0.14	0.31	0.31	0.32	0.18	0.27	0.29	0.38	0.31	0.27	0.15	-0.1	1.0	0.24	0.41	0.11	-0.21	0.41		0.64	0.52	0.52	-0.2
Interest Income	0.7	-0.29	0.52	0.51	0.44	0.61	0.72	0.73	0.58	0.43	0.73	0.46	0.5	0.66	0.28	0.64	0.16	0.37	0.59	0.64		0.86	0.74	-0.38
Net Interest Income	0.73	-0.57	0.81	0.8	0.78	0.64	0.75	0.76	0.73	0.77	0.75	0.27	0.56	0.56	0.67	0.87	0.27	0.45	0.49	0.52	0.86		0.82	-0.67
Reconciled Depreciation	0.62	-0.46	0.77	0.77	0.7	0.79	0.85	0.85	0.72	0.68	0.83	0.17	0.65	0.55	0.53	0.87	0.38	0.57	0.59	0.52	0.74	0.82		-0.71
Selling And Marketing Expenses	-0.27	0.58	-0.87	-0.87	-0.87	-0.63	-0.67	-0.66	-0.71	-0.86	-0.65	-0.16	-0.59	-0.23	-0.8	-0.86	-0.23	-0.55	-0.53	-0.2	-0.38	-0.67	-0.71

Click cells to compare fundamentals

Incyte Account Relationship Matchups

Incyte income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	71.9M	23.2M	25.4M	52.1M	82.7M	86.8M
Interest Expense	1.9M	2.2M	1.9M	2.7M	2.6M	2.4M
Total Revenue	2.2B	2.7B	3.0B	3.4B	3.7B	3.9B
Gross Profit	2.0B	2.5B	2.8B	3.2B	3.4B	3.6B
Other Operating Expenses	1.7B	2.9B	2.4B	2.8B	3.0B	3.2B
Operating Income	402.0M	(240.3M)	585.8M	579.4M	620.5M	651.6M
Ebit	402.0M	(240.3M)	585.8M	579.4M	822.1M	863.2M
Ebitda	473.9M	(217.1M)	611.2M	631.5M	904.7M	950.0M
Cost Of Revenue	114.2M	131.3M	151.0M	207.0M	255M	267.8M
Total Operating Expenses	1.6B	2.8B	2.2B	2.6B	2.8B	2.9B
Income Before Tax	486.8M	(232.2M)	570.4M	529.1M	834.2M	875.9M
Total Other Income Expense Net	84.8M	8.1M	(15.3M)	(50.3M)	14.7M	15.4M
Net Income	446.9M	(295.7M)	948.6M	340.7M	597.6M	627.5M
Income Tax Expense	39.9M	63.5M	(378.1M)	188.5M	236.6M	248.4M
Research Development	1.2B	2.2B	1.5B	1.6B	1.6B	1.7B
Selling General Administrative	453.4M	516.9M	739.6M	1.0B	1.2B	1.2B
Net Income From Continuing Ops	446.9M	(295.7M)	948.6M	340.7M	425.0M	446.2M
Non Operating Income Net Other	52.2M	23.2M	10.6M	39.9M	45.9M	48.2M
Net Income Applicable To Common Shares	446.9M	(295.7M)	948.6M	340.7M	391.8M	411.3M
Tax Provision	39.9M	63.5M	(378.1M)	188.5M	218.9M	229.8M
Interest Income	45.6M	84.8M	10.6M	39.9M	172.3M	181.0M
Net Interest Income	(1.9M)	(2.2M)	(1.9M)	(2.7M)	106.2M	111.5M
Reconciled Depreciation	54.5M	51.8M	57.8M	67.9M	79.1M	65.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:

How To Invest In Incyte

Details

Is Incyte Stock a good investment?

Details

What is Incyte's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.

	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	CEOs Directory Screen CEOs from public companies around the world
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Money Managers Screen money managers from public funds and ETFs managed around the world

Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

6.324

Earnings Share

2.65

Revenue Per Share

16.526

Quarterly Revenue Growth

0.093

Return On Assets

0.0646

The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Incyte Historical Income Statement

About Incyte Income Statement Analysis

Incyte Income Statement Chart

Total Revenue

Other Operating Expenses

Cost Of Revenue

Total Operating Expenses

Incyte income statement Correlations

Incyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Incyte income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Incyte Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda
Tax Provision	+ 1.0	Income Tax Expense

Selling And Marketing Expenses	- 0.87	Other Operating Expenses
Selling And Marketing Expenses	- 0.87	Gross Profit
Selling And Marketing Expenses	- 0.87	Total Revenue
Selling And Marketing Expenses	- 0.86	Selling General Administrative
Selling And Marketing Expenses	- 0.86	Total Operating Expenses
Selling And Marketing Expenses	- 0.8	Research Development